Ligand Pharmaceuticals Inc (LGND)
115.58
-6.49
(-5.32%)
USD |
NASDAQ |
Nov 14, 16:00
115.58
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Return Level: 199.94 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 13, 2024 | 199.94 |
| November 12, 2024 | 197.76 |
| November 11, 2024 | 202.23 |
| November 08, 2024 | 198.60 |
| November 07, 2024 | 212.77 |
| November 06, 2024 | 191.47 |
| November 05, 2024 | 182.02 |
| November 04, 2024 | 180.53 |
| November 01, 2024 | 180.24 |
| October 31, 2024 | 173.13 |
| October 30, 2024 | 179.86 |
| October 29, 2024 | 189.23 |
| October 28, 2024 | 185.71 |
| October 25, 2024 | 183.15 |
| October 24, 2024 | 181.79 |
| October 23, 2024 | 175.08 |
| October 22, 2024 | 174.44 |
| October 21, 2024 | 174.90 |
| October 18, 2024 | 174.26 |
| October 17, 2024 | 173.44 |
| October 16, 2024 | 175.52 |
| October 15, 2024 | 170.98 |
| October 14, 2024 | 169.46 |
| October 11, 2024 | 168.61 |
| October 10, 2024 | 164.32 |
| Date | Value |
|---|---|
| October 09, 2024 | 169.10 |
| October 08, 2024 | 168.66 |
| October 07, 2024 | 168.08 |
| October 04, 2024 | 171.62 |
| October 03, 2024 | 167.46 |
| October 02, 2024 | 163.71 |
| October 01, 2024 | 166.00 |
| September 30, 2024 | 163.94 |
| September 27, 2024 | 159.48 |
| September 26, 2024 | 162.78 |
| September 25, 2024 | 161.79 |
| September 24, 2024 | 163.04 |
| September 23, 2024 | 163.23 |
| September 20, 2024 | 168.38 |
| September 19, 2024 | 172.00 |
| September 18, 2024 | 169.82 |
| September 17, 2024 | 170.77 |
| September 16, 2024 | 171.98 |
| September 13, 2024 | 171.60 |
| September 12, 2024 | 167.23 |
| September 11, 2024 | 168.85 |
| September 10, 2024 | 167.44 |
| September 09, 2024 | 168.34 |
| September 06, 2024 | 165.66 |
| September 05, 2024 | 168.95 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
66.98
Minimum
Mar 16 2020
228.12
Maximum
Feb 09 2021
121.88
Average
117.41
Median
Feb 06 2023
Total Return Level Benchmarks
| Regeneron Pharmaceuticals Inc | 804.33 |
| Agios Pharmaceuticals Inc | 58.58 |
| ADMA Biologics Inc | 21.48 |
| Pieris Pharmaceuticals Inc | 16.10 |
| AnaptysBio Inc | 20.77 |